PT - JOURNAL ARTICLE AU - Aksoy, Cevat Giray AU - Ganslmeier, Michael AU - Poutvaara, Panu TI - Public attention and policy responses to COVID-19 pandemic <sup>⋆</sup> AID - 10.1101/2020.06.30.20143420 DP - 2020 Jan 01 TA - medRxiv PG - 2020.06.30.20143420 4099 - http://medrxiv.org/content/early/2020/07/03/2020.06.30.20143420.short 4100 - http://medrxiv.org/content/early/2020/07/03/2020.06.30.20143420.full AB - Early non-pharmaceutical interventions (NPI) significantly reduced the death toll of the COVID-19 pandemic. Yet, there are vast differences in how quickly governments implemented NPIs. In this paper, we analyze the role of public attention, measured as the share of daily Google searches in a country related to COVID-19, in the timing of the NPI responses. We first show that public attention depends strongly on whether there are cases in own country. We then show that countries with high levels of public attention are more likely to implement non-pharmaceutical interventions, even after controlling for the number of cases and deaths. Finally, we show that the extent to which a government responds to public attention is highly dependent on the country’s institutional quality. The positive effect of public attention on policy implementation is driven entirely by countries with good institutions.Competing Interest StatementThe authors have declared no competing interest.Funding StatementNo external funding was received.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:The research did not need IRB approval as we used publicly available data and data from Google Health Trends API for which we applied and obtained access for research purposes.All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesWe used publicly available data and data from Google Health Trends API for which we applied and obtained access for research purposes. Publicly available data consists of: (1) Hale, T., Webster, S., Petherick, A., Phillips, T. &amp; Kira, B. (2020). Oxford COVID-19 Government Response Tracker, Blavatnik School of Government. Data use policy: Creative Commons Attribution CC BY standard. Available at: https://www.bsg.ox.ac.uk/research/research-projects/coronavirus-government-response-tracker (2) Johns Hopkins University, COVID-19 Data Repository by the Center for Sys-tems Science and Engineering (CSSE) (2020); Cases: https://raw.githubusercontent.com/CSSEGISandData/COVID-19/master/csse_covid_19_data/csse_covid_19_time_series/time_series_covid19_confirmed_US.csv; Deaths: https://raw.githubusercontent.com/CSSEGISandData/COVID-19/master/csse_covid_19_data/csse_covid_19_time_series/time_series_covid19_deaths_global.csv (3) World Bank. Worldwide Governance Indicators (WGI) Project. The World Bank, Washington DC, USA (2018). Available at: https://info.worldbank.org/governance/wgi/